Clinical Trial Update: EVA: Evista Alendronate Comparison [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Evista (raloxifene) with alendronate for osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Evista (raloxifene)
• alendronate (alendronate)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoporosis | Phase 4 | Status: COMPLETED